Live Breaking News & Updates on Has Activity

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
Corbus Pharmaceuticals Holdings, Inc.
Norwood, Massachusetts, UNITED STATES
Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist metabolism program
Norwood, MA, Jan. 20, 2021 (GLOBE NEWSWIRE) Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced it will participate in the New York Academy of Sciences’
webinar on January 27, 2021 on the endocannabinoid system as a target for therapeutic agents. ....

New York , United States , New York Academy Of Sciences , Lindsey Smith , Derek Gilroy , Ping Zhang , Ted Jenkins , Barbara White , University College London , Head Of Research , Corbus Pharmaceuticals Holdings Inc , Exchange Commission , Corbus Pharmaceuticals Contacts , York Academy Of Science , Academy Of Sciences , Corporate Communications , Securities Exchange , York Academy Of Sciences , Pharmaceuticals Holdings , New York Academy , New Insights , Acute Inflammation , Humans Provided , Synthetic Analogue , University College , Therapeutic Potential ,